MoneyWorks4Me

Dr Reddy's Laboratories reports many fold jump in Q3 consolidated net profit

28 Jan 2022 Evaluate

Dr Reddy's Laboratories has reported results for third quarter ended December 31, 2021.

The company has reported fall of 23.12% in its net profit at Rs 341.10 crore for the quarter under review as compared to Rs 443.70 crore for the same quarter in the previous year. However, total income of the company increased by 2.06% at Rs 3542.60 crore for Q3FY22 as compared Rs 3471.00 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported above 25-fold jump in its net profit at Rs 709.30 crore for the quarter under review as compared to Rs 27.90 crore for the same quarter in the previous year. Total income of the company increased by 7.62% at Rs 5394.10 crore for Q3FY22 as compared Rs 5012.40 crore for the corresponding quarter previous year.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..